Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Front Endocrinol (Lausanne). 2023 Feb 16;14:1087614. doi: 10.3389/fendo.2023.1087614. eCollection 2023.
Some studies have reported that the topical forms with aminophylline as the active ingredient appear to be relatively effective on local fat burning while having no/minimal side effects. This systematic review accumulates all of the data on the local fat-burning potency of aminophylline topical formulation.
Documents were retrieved from PubMed, Web of Science, and Scopus databases until Aug 2022. Data were extracted from clinical trials reporting the reduction in thigh or waist circumference as a result of using topical forms containing aminophylline. Screening of included studies was performed independently by two authors and the quality assessment of included studies was performed based on the Cochrane Collaboration's approach.
Of the 802 initial studies, 5 studies were included in the systematic review. Several concentrations of aminophylline were used in different studies. Most studies administred the topical formulation on participants' one thigh, and the other thigh was considered to be the control for comparing the fat reduction amount. Except for one study, all other studies reported that all participants lost more fat on the treated area than the control groups. The amount of fat reduction differed in studies regarding their different aminophylline concentrations and administration routines. In the case of side effects, except for some studies reporting skin rashes, other studies reported no significant side effects at all.
Aminophylline topical formulation offers a safe, effective, and much less invasive alternative to cosmetic surgery for localized fat reduction. It seems that the 0.5% concentration, administered five times a week for five weeks is the most potent concentration. However, more high-quality clinical trials are needed to verify this conclusion.
https://www.crd.york.ac.uk/prospero/, identifier CRD42022353578.
一些研究报告称,含有氨茶碱的局部用制剂在局部减脂方面似乎相对有效,且副作用较小或没有。本系统评价汇总了所有关于氨茶碱局部制剂局部减脂效果的数据。
从 PubMed、Web of Science 和 Scopus 数据库中检索到 2022 年 8 月之前的文献。从报告使用含有氨茶碱的局部制剂可减少大腿或腰围的临床试验中提取数据。两名作者独立筛选纳入研究,并基于 Cochrane 协作方法评估纳入研究的质量。
在 802 篇初始研究中,有 5 项研究纳入了系统评价。不同研究中使用了不同浓度的氨茶碱。大多数研究将局部制剂涂抹在参与者的一条大腿上,另一条大腿被认为是对照组,用于比较脂肪减少量。除了一项研究外,所有其他研究均报告说,治疗区域的参与者比对照组减少了更多的脂肪。关于不同的氨茶碱浓度和给药方案,研究中的脂肪减少量存在差异。在副作用方面,除了一些研究报告皮肤疹外,其他研究均未报告任何明显的副作用。
氨茶碱局部制剂为局部减脂提供了一种安全、有效且侵入性较小的替代美容手术的方法。0.5%浓度,每周 5 次,连续 5 周似乎是最有效的浓度。然而,需要更多高质量的临床试验来验证这一结论。
https://www.crd.york.ac.uk/prospero/,标识符 CRD42022353578。